CCNF and pancreatic ductal adenocarcinoma: Of 68 pancreatic ductal adenocarcinomas, 43 (63.24%) demonstrated cyclin F immunoreactivity, while normal pancreatic ductal epithelium was mostly non-reactive (n = 59/65; 90.77%).